PENUMBRA INC (PEN)
US70975L1070 - Common Stock
Overall PEN gets a fundamental rating of 6 out of 10. We evaluated PEN against 187 industry peers in the Health Care Equipment & Supplies industry. PEN has an excellent financial health rating, but there are some minor concerns on its profitability. PEN is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes PEN very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year PEN was profitable.
In the past year PEN had a positive cash flow from operations.
In multiple years PEN reported negative net income over the last 5 years.
In multiple years PEN reported negative operating cash flow during the last 5 years.
1.2 Ratios
PEN has a better Return On Assets (2.34%) than 73.80% of its industry peers.
PEN has a better Return On Equity (3.13%) than 75.40% of its industry peers.
With an excellent Return On Invested Capital value of 6.66%, PEN belongs to the best of the industry, outperforming 83.42% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PEN is significantly below the industry average of 8.19%.
The last Return On Invested Capital (6.66%) for PEN is above the 3 year average (2.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.13% | ||
| ROIC | 6.66% |
ROA(3y)2.04%
ROA(5y)2.3%
ROE(3y)2.69%
ROE(5y)3.12%
ROIC(3y)2.28%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PEN (2.97%) is better than 73.80% of its industry peers.
PEN's Profit Margin has improved in the last couple of years.
The Operating Margin of PEN (9.61%) is better than 78.07% of its industry peers.
In the last couple of years the Operating Margin of PEN has grown nicely.
With a decent Gross Margin value of 65.70%, PEN is doing good in the industry, outperforming 68.98% of the companies in the same industry.
In the last couple of years the Gross Margin of PEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.61% | ||
| PM (TTM) | 2.97% | ||
| GM | 65.7% |
OM growth 3YN/A
OM growth 5Y5.22%
PM growth 3YN/A
PM growth 5Y42.09%
GM growth 3Y2.24%
GM growth 5Y-0.38%
2. Health
2.1 Basic Checks
PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PEN has been increased compared to 1 year ago.
The number of shares outstanding for PEN has been increased compared to 5 years ago.
PEN has a better debt/assets ratio than last year.
2.2 Solvency
PEN has an Altman-Z score of 16.56. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 16.56, PEN belongs to the top of the industry, outperforming 93.05% of the companies in the same industry.
The Debt to FCF ratio of PEN is 0.18, which is an excellent value as it means it would take PEN, only 0.18 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.18, PEN belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that PEN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.02, PEN is doing good in the industry, outperforming 64.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.18 | ||
| Altman-Z | 16.56 |
ROIC/WACC0.73
WACC9.15%
2.3 Liquidity
PEN has a Current Ratio of 5.82. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN has a Current ratio of 5.82. This is amongst the best in the industry. PEN outperforms 80.75% of its industry peers.
A Quick Ratio of 3.25 indicates that PEN has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.25, PEN is doing good in the industry, outperforming 66.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.82 | ||
| Quick Ratio | 3.25 |
3. Growth
3.1 Past
PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.52%, which is quite impressive.
Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.59% on average per year.
Looking at the last year, PEN shows a quite strong growth in Revenue. The Revenue has grown by 16.96% in the last year.
Measured over the past years, PEN shows a quite strong growth in Revenue. The Revenue has been growing by 18.93% on average per year.
EPS 1Y (TTM)78.52%
EPS 3Y126.44%
EPS 5Y32.59%
EPS Q2Q%26.87%
Revenue 1Y (TTM)16.96%
Revenue growth 3Y23.61%
Revenue growth 5Y18.93%
Sales Q2Q%11.11%
3.2 Future
The Earnings Per Share is expected to grow by 29.72% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.32% on average over the next years. This is quite good.
EPS Next Y35.07%
EPS Next 2Y35.75%
EPS Next 3Y33.99%
EPS Next 5Y29.72%
Revenue Next Year12.23%
Revenue Next 2Y13.35%
Revenue Next 3Y13.57%
Revenue Next 5Y13.32%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 91.18, the valuation of PEN can be described as expensive.
PEN's Price/Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 64.71% of the companies in the same industry.
PEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
PEN is valuated quite expensively with a Price/Forward Earnings ratio of 62.97.
Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than 68.45% of the companies in the same industry.
PEN is valuated expensively when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 91.18 | ||
| Fwd PE | 62.97 |
4.2 Price Multiples
64.71% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 70.59% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 69.37 | ||
| EV/EBITDA | 65.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
PEN's earnings are expected to grow with 33.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.6
PEG (5Y)2.8
EPS Next 2Y35.75%
EPS Next 3Y33.99%
5. Dividend
5.1 Amount
PEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PENUMBRA INC
NYSE:PEN (12/20/2024, 8:04:00 PM)
After market: 242.54 0 (0%)242.54
-0.98 (-0.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.36%
Inst Owner Change1.6%
Ins Owners3.8%
Ins Owner Change0.52%
Market Cap9.31B
Analysts79.13
Price Target240.21 (-0.96%)
Short Float %5.02%
Short Ratio5.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.03%
Min EPS beat(2)13.6%
Max EPS beat(2)22.45%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.31%
Max EPS beat(4)22.45%
EPS beat(8)8
Avg EPS beat(8)33.42%
EPS beat(12)10
Avg EPS beat(12)20.39%
EPS beat(16)13
Avg EPS beat(16)68.98%
Revenue beat(2)1
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)0.22%
Revenue beat(4)2
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-1.64%
Max Revenue beat(4)0.37%
Revenue beat(8)6
Avg Revenue beat(8)0.81%
Revenue beat(12)8
Avg Revenue beat(12)1.12%
Revenue beat(16)12
Avg Revenue beat(16)2.67%
PT rev (1m)8.12%
PT rev (3m)20.2%
EPS NQ rev (1m)0.93%
EPS NQ rev (3m)-12.03%
EPS NY rev (1m)0.48%
EPS NY rev (3m)6.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.59%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 91.18 | ||
| Fwd PE | 62.97 | ||
| P/S | 8 | ||
| P/FCF | 69.37 | ||
| P/OCF | 60.59 | ||
| P/B | 8.43 | ||
| P/tB | 10 | ||
| EV/EBITDA | 65.36 |
EPS(TTM)2.66
EY1.1%
EPS(NY)3.85
Fwd EY1.59%
FCF(TTM)3.5
FCFY1.44%
OCF(TTM)4
OCFY1.65%
SpS30.32
BVpS28.77
TBVpS24.26
PEG (NY)2.6
PEG (5Y)2.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.13% | ||
| ROCE | 8.43% | ||
| ROIC | 6.66% | ||
| ROICexc | 8.54% | ||
| ROICexgc | 10.25% | ||
| OM | 9.61% | ||
| PM (TTM) | 2.97% | ||
| GM | 65.7% | ||
| FCFM | 11.53% |
ROA(3y)2.04%
ROA(5y)2.3%
ROE(3y)2.69%
ROE(5y)3.12%
ROIC(3y)2.28%
ROIC(5y)N/A
ROICexc(3y)2.88%
ROICexc(5y)N/A
ROICexgc(3y)3.74%
ROICexgc(5y)N/A
ROCE(3y)2.89%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-5.74%
ROICexc growth 3YN/A
ROICexc growth 5Y-7.37%
OM growth 3YN/A
OM growth 5Y5.22%
PM growth 3YN/A
PM growth 5Y42.09%
GM growth 3Y2.24%
GM growth 5Y-0.38%
F-Score7
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.18 | ||
| Debt/EBITDA | 0.16 | ||
| Cap/Depr | 73.83% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 111.18% | ||
| Profit Quality | 388.4% | ||
| Current Ratio | 5.82 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 16.56 |
F-Score7
WACC9.15%
ROIC/WACC0.73
Cap/Depr(3y)88.08%
Cap/Depr(5y)145.86%
Cap/Sales(3y)2.18%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.52%
EPS 3Y126.44%
EPS 5Y32.59%
EPS Q2Q%26.87%
EPS Next Y35.07%
EPS Next 2Y35.75%
EPS Next 3Y33.99%
EPS Next 5Y29.72%
Revenue 1Y (TTM)16.96%
Revenue growth 3Y23.61%
Revenue growth 5Y18.93%
Sales Q2Q%11.11%
Revenue Next Year12.23%
Revenue Next 2Y13.35%
Revenue Next 3Y13.57%
Revenue Next 5Y13.32%
EBIT growth 1Y81.85%
EBIT growth 3YN/A
EBIT growth 5Y25.14%
EBIT Next Year84.18%
EBIT Next 3Y43.11%
EBIT Next 5Y32.8%
FCF growth 1Y248.93%
FCF growth 3YN/A
FCF growth 5Y33.72%
OCF growth 1Y331.83%
OCF growth 3YN/A
OCF growth 5Y27.57%